Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

Unicycive Therapeutics, Inc. (UNCY) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 8-K Quarterly results
07/26/2023 8-K Quarterly results
05/23/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/16/2023 8-K Quarterly results
Docs: "Unicycive Announces First Quarter 2023 Financial Results and Provides Business Update"
03/31/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Unicycive Announces Full Year 2022 Financial Results and Provides Business Update"
03/30/2023 8-K Quarterly results
03/06/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Voting Preferred Stock",
"Form of Specimen Stock Certificate for Series A-1 Preferred Stock",
"Form of Tranche A Warrant",
"Form of Tranche B Warrant",
"Form of Tranche C Warrant",
"Form of Securities Purchase Agreement, by and between Unicycive Therapeutics, Inc. and the purchasers named therein",
"Placement Agency Agreement, by and between Unicycive Therapeutics, Inc. and EF Hutton, division of Benchmark Investments, LLC",
"Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb"
03/02/2023 8-K Other Events  Interactive Data
02/07/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
02/02/2023 8-K Quarterly results
12/29/2022 8-K Quarterly results
12/28/2022 8-K Investor presentation
Docs: "Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of Renazorb",
"CORPORATE PRESENTATION OF UNICYCIVE THERAPEUTICS, INC"
11/14/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
07/18/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/31/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Unicycive Announces Full Year 2021 Financial Results and Provides Business Update"
11/29/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SOURCE: Unicycive Therapeutics, Inc."
11/12/2021 8-K Quarterly results
Docs: "Unicycive Therapeutics Announces Third Quarter 2021 Financial Results"
08/16/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy